[ET Net News Agency, 24 March 2026] INNOGEN-B (02591) rose 19.2% to HK$24.1.
It hits an intra-day high of HK$24.72, breaking above the 20-D SMA of HK$23.696, and an intra-day low of HK$19.05, hitting a historical low. The total shares traded was 1.18 million, with a value of HK$27.39m. The active buy/sell ratio is 48:52, with net selling turnover of HK$1.26m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$2.09m, with volume weighted average price of HK$23.358. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$713,099, with volume weighted average price of HK$22.601.
Basic Information| Nominal | 24.100 | % Chg | +19.19% |
| High | 24.720 | Low | 19.050 |
| Shares Tr | 1.18m | Turnover | 27.39m |
| 10-D SMA | 22.306 | %H.V | 58.230 |
| 20-D SMA | 23.696 | VWAP | 23.206 |
| 50-D SMA | 27.089 | RSI14 | 48.785 |
Status: Breaking above the 20-D SMA, hitting a historical low, active buy/sell ratio is 48:52, with net selling turnover of HK$1.26m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 24.10 | +19.19 |
| INNOVENT BIO (01801) | 79.15 | +2.13 |
| KEYMED BIO-B (02162) | 53.35 | +5.75 |
| XTALPI (02228) | 8.84 | -0.90 |
| WUXI XDC (02268) | 56.25 | +10.73 |
| WUXI BIO (02269) | 33.32 | +2.84 |
| BEONE MEDICINES (06160) | 163.60 | +1.05 |
| DUALITYBIO-B (09606) | 261.00 | -3.26 |
| AKESO (09926) | 114.00 | +1.69 |
| REMEGEN (09995) | 88.05 | +0.80 |
(ed)
Nominal 